| Barchart Demo Center |
$0.95
-0.04 (-4.04%)
as of 14:20 EDT
as of 14:20 EDT
| Last | 0.95 |
|---|---|
| Change | -0.04 (-4.04%) |
| Open | 0.98 |
| Prev. Close | 0.99 |
| Today's Range |
0.95
0.99
|
| 52wk Range |
0.66
3.88
|
| Volume | 144,053 |
| Avg Volume | 492,365 |
| Sector | All Sectors By Industry |
Perfomance Comparison
| Name | Today | 3-Month | 1-Year |
|---|---|---|---|
| BIOC |
 -4.04% |
 -10.95% |
-72.91% |
| DJIA |
-1.94% |
-1.37% |
 +0.36% |
| S&P 500 |
-2.10% |
-0.99% |
 +0.21% |
Key Statistics
| Annual EPS | -4.84 |
|---|---|
| Dividend Yield | 0.00% |
| P/E Ratio | N/A |
| Market Capitalization, $K | 22,330 |
| Weighted Alpha | -76.98 |
| Standard Deviation | -0.89 |
| Profit Margin | 3.63% |
| Beta | 1.93 |
Growth Rates
| YTD | +11.83% | |||
| 1-Year | -69.11% | |||
| 3-Year | -98.10% | |||
| 5-Year | -99.73% |
Opinion
| Sell | Hold | Buy |
Recent Headlines
High Sensitivity of Biocept's Target Selector(TM)
PR Newswire via COMTEX - Thu Aug 22, 08:05AM EDT
Biocept, Inc. (NASDAQ: BIOC), a leading commercial provider of liquid biopsy tests designed to provide physicians with clinically actionable information to improve the outcomes of patients diagnosed with cancer, announces that cli(full story)
BIOC: 0.95 (-0.04)
Biocept Receives Three Additional Patents Covering its
PR Newswire via COMTEX - Tue Aug 13, 08:05AM EDT
Biocept, Inc. (NASDAQ: BIOC), a leading commercial provider of liquid biopsy tests designed to provide physicians with clinically actionable information to improve the outcomes of patients diagnosed with cancer, announces that it (full story)
BIOC: 0.95 (-0.04)
Biocept Reports Second Quarter 2019 Financial Results
PR Newswire via COMTEX - Mon Aug 12, 04:05PM EDT
Biocept, Inc. (NASDAQ: BIOC), a leading commercial provider of liquid biopsy tests designed to provide physicians with clinically actionable information to improve the outcomes of cancer patients, reports financial results for the(full story)
BIOC: 0.95 (-0.04)
Biocept, Inc. to Host Earnings Call
ACCESSWIRE via COMTEX - Mon Aug 12, 02:37PM EDT
NEW YORK, NY / ACCESSWIRE / August 12, 2019 / Biocept, Inc. (NASDAQ: ) will be discussing their earnings results in their 2019 Second Quarter Earnings to be held on August 12, 2019 at 4:30 PM Eastern Time.(full story)
BIOC: 0.95 (-0.04)
Biocept to Release Second Quarter 2019 Financial
PR Newswire via COMTEX - Mon Aug 05, 08:05AM EDT
Biocept, Inc. (NASDAQ: BIOC), a leading commercial provider of liquid biopsy tests designed to provide physicians with clinically actionable information to improve the outcomes of patients diagnosed with cancer, announces that it (full story)
BIOC: 0.95 (-0.04)